EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti‐IL‐4Rα therapy

K Pažur, W Francuzik iD, H El-Mahmoud, M Kraft, M Worm

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von K Pažur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Biomarkers, Proteomics, MicroRNAs. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identification of biomarkers is required for a systems medicine approach and personalized treatment in atopic dermatitis (AD). These biomarkers may not only aid in diagnosing but also might be suitable to predict the effectiveness of targeted treatment.

Objective

We aimed to identify proteomic, microbial and miRNA biomarkers in AD patients and investigated their course in relation to the clinical response upon anti‐IL‐4Rα therapy.

Methods

Proteomic and miRNA screening was performed in AD patients in comparison to healthy controls. Differentially regulated serum proteins, miRNA and selected skin microbiota were measured consecutively in 50 AD patients before and upon systemic dupilumab treatment. A random forest classifier was used to predict the outcome of dupilumab therapy based on the initial biomarker patterns.

Results

We identified 27 proteomic candidates, miRNA and three microbial strains to be dysregulated in AD. CCL17, CCL13, CCL22, E‐selectin and BDNF were differently regulated and significantly associated with treatment response. In contrast, neither the microbial composition nor the miRNA pattern was associated with treatment response upon dupilumab treatment.

Conclusion

AD patients display defined dysregulations regarding their systemic proteomic serum profile, miRNA patterns and their skin microbiome. The proteomic profile and selected skin bacteria changed profoundly upon anti‐IL‐4Rα therapy which was associated with an overall clinical response. This was not seen in miRNA‐related biomarkers. Our findings support the hypothesis that biomarker profiles reflect treatment responses and may in the future be used to develop a personalized medicine approach for the treatment of AD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicBiomarkersProteomicsMicroRNAsAntibodies, Monoclonal, HumanizedHumansMaleFemaleAdultMiddle AgedSkinCase-Control StudiesYoung AdultMicrobiotaInterleukin-4 Receptor alpha Subunit

Substanzen

dupilumabBiomarkersMicroRNAsAntibodies, Monoclonal, HumanizedInterleukin-4 Receptor alpha Subunit

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: W Francuzik

Förderung

  • Sanofi

Zitieren

APA

Pažur, K., Francuzik, W., El-Mahmoud, H., Kraft, M., & Worm, M. (2024). Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti‐IL‐4Rα therapy. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19911

Vancouver

Pažur K, Francuzik W, El-Mahmoud H, Kraft M, Worm M. Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti‐IL‐4Rα therapy. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19911

BibTeX
@article{Paur2024,
  author = {Pažur, K and Francuzik, W and El-Mahmoud, H and Kraft, M and Worm, M},
  title = {Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti‐IL‐4Rα therapy},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19911}
}
Kostenlos starten →